Left ventricular thrombus

Source: Wikipedia, the free encyclopedia.
Left ventricular thrombus
Blood clots in the ventricle found on autopsy

Left ventricular thrombus is a blood clot (

left ventricle of the heart. LVT is a common complication of acute myocardial infarction (AMI).[1][2] Typically the clot is a mural thrombus, meaning it is on the wall of the ventricle.[3] The primary risk of LVT is the occurrence of cardiac embolism,[1][4] in which the thrombus detaches from the ventricular wall and travels through the circulation and blocks blood vessels. Blockage can be especially damaging in the heart or brain (stroke).[1][5]

Pathophysiology

LVT occurs most often during the first 2 weeks following AMI.[1] AMI patients most at risk display the 3 characteristics of Virchow's triad:[1]

Stagnation of blood

The risk of LVT formation increases as infarction size increases.[5] A larger infarction means a larger area of tissue injury, which may be akinetic or dyskinetic, resulting in stagnation of ventricular blood.[1]

Endothelial injury

platelets.[1]

Hypercoagulable state

For several days after AMI, the levels of tissue factor and D-dimer, which are involved in coagulation, are high, which increases the risk of LVT formation.[7] LVT may be good for the heart when tissues are severely damaged because it acts to thicken the wall, thus protecting it against rupture.[1]

Diagnosis

Magnetic Resonance Imaging are effective, but less common ways to detect LVT, due to their costs and risks.[1] It is possible to assess whether a thrombus will become an embolus through echocardiography. Mobility and protrusion of the thrombus are two characteristics associated with increased embolic potential.[8]

Prevention

After an AMI, people should be treated to prevent LVT formation. Aspirin plus an oral anticoagulant such as warfarin are suggested for individuals at risk for thromboembolic events.[10] Anticoagulants are also shown to reduce the risk of embolisms[1][4] when a thrombus is already formed. Heparin, an injectable, fast-acting anticoagulant, is effective in high doses for preventing LVT formation after AMI.[1][11]

Treatment

Systemic anticoagulation is considered first-line medical therapy for LVT, as it reduces the risk of systemic embolism.[12][10] There are also surgical procedures for removal of a thrombus (thrombectomy).

Epidemiology

The rate of LVT formation after AMI is thought to be declining[13][14] due to the use of better therapies and percutaneous coronary intervention used to treat myocardial infarction.[1][5][7][15] In the modern era LVT formation after ST elevation MI treated with percutaneous coronary intervention is low, estimated at only 2.7%.[16] However, incidence of LVT is considered higher in anterior wall AMI, compared with other types.[17]

References

External links